Retroviral integration requires cis-acting sequences at the termini of linear double-stranded viral DNA and a product of the retroviral pol gene, the integrase protein (IN). IN is required and sufficient for generation of recessed 3' termini of the viral DNA (the first step in proviral integration) and for integration of the recessed DNA species in vitro. Human immunodeficiency virus type 1 (HIV-1) IN, expressed in Escherichia coli, was purified to near homogeneity. The substrate sequence requirements for specific cleavage and integration of retroviral DNA were studied in a physical assay, using purified IN and short duplex oligonucleotides that correspond to the termini of HIV DNA. A few point mutations around the IN cleavage site substantially reduced cleavage; most other mutations did not have a drastic effect, suggesting that the sequence requirements are limited. The terminal 15 bp of the retroviral DNA were demonstrated to be sufficient for recognition by IN. Efficient specific cutting of the retroviral DNA by IN required that the cleavage site, the phosphodiester bond at the 3' side of a conserved CA-3' dinucleotide, be located two nucleotides away from the end of the viral DNA, however, low-efficiency cutting was observed when the cleavage site was located one, three, four, or five nucleotides away from the terminus of the double-stranded viral DNA. Increased cleavage by IN was detected when the nucleotides 3' of the CA-3' dinucleotide were present as single-stranded DNA. IN was found to have a strong preference for promoting integration into double-stranded rather than single-stranded DNA.
Efficient retroviral replication requires integration of a double-stranded DNA copy of the viral RNA genome into a chromosome of the infected cell. Transcription of the integrated provirus produces viral RNAs that function as genomes of progeny virions or as the template for translation of viral proteins. Assembled virions bud from the cell membrane, and infection of other cells completes the retroviral replication cycle.
Studies of integration in the Moloney murine leukemia virus (MoMLV), human immunodeficiency virus (HIV), and avian sarcoma-leukosis virus (ASLV) systems have indicated that the following steps are involved in the integration process. After reverse transcription and second-strand DNA synthesis, a linear, double-stranded DNA molecule with flush ends is formed. This DNA copy of the viral RNA contains at its termini direct repeat sequences, termed long terminal repeats (LTRs) . At the outer edges of the LTRs, short, imperfect inverted repeats are present. These sequences are necessary and sufficient for correct proviral integration (6, 7) . The two terminal nucleotides at the 3' ends of the blunt-ended DNA are cleaved off, resulting in the putative immediate precursor for integration (2, 15, 26) . This cleavage reaction is executed by the viral integrase protein (IN), which is the only protein known to be required for integration (3, 5, 8, 18, 19, 30) . In the next step, the target DNA is cut in a staggered fashion and joined to the viral 3' OH ends (3, 8, 15, 18) . The length of the staggered cut is virus specific (35) . In the case of HIV integration, presumably a 5-bp staggered cut is generated, which is inferred from the characteristic 5-bp direct repeats in the target DNA that flank integrated HIV proviruses (10, 21, 36) . The last step in * Corresponding author. proviral integration is repair of the single-stranded DNA gaps present in the integration intermediate. It is possibly in this step that the terminal nucleotides at the proviral 5' ends are lost. The resulting provirus is now flanked by a short direct duplication of the target DNA and terminates with the dinucleotides 5'-TG and CA-3'. These same dinucleotides are also present at the termini of some eukaryotic and prokaryotic transposable elements and in all retrotransposons.
The HIV-1 IN protein is encoded near the 3' end of the viral pol gene and is a 32-kDa proteolytic cleavage product of a gag-pol fusion protein precursor. Mutations in the INcoding region have no influence on reverse transcription, but integration of the viral DNA can be blocked (9, 28, 34 ). An understanding of the role of the IN protein in the integration process has come from the development of different in vitro integration assays. First it was shown that extracts from retrovirus-infected cells were able to integrate endogenous DNA as well as exogenously added retroviral DNA (2, 10, 11, 14, 37) . Thereafter it was demonstrated by a direct physical assay that the IN proteins of HIV, MoMLV, and ASLV are the only viral proteins that are required both to generate the recessed 3' ends of the viral DNA and to accomplish their integration in vitro (4, 8, 18, 30) . In this assay, oligonucleotides that represent the termini of the retroviral DNA were incubated with IN, and it was shown that besides specific cutting of the oligonucleotides, IN is also capable of integrating one oligonucleotide into another.
The IN protein of HIV-1 has been overexpressed in insect cells (5) . This protein was partially purified, and it was shown that it is able to promote integration of mini-HIV DNA in a genetic assay. HIV-1 IN was also overproduced in and partially purified from Escherichia coli (4, 30) . For We overproduced HIV-1 IN in E. coli and purified it to near homogeneity. We show here that IN has specific integration activity as well as specific cleavage activity. The sequence requirements for efficient specific cleavage and integration of HIV DNA were investigated by using a series of oligonucleotides that contain mutations relative to an oligonucleotide that mimics the ends of HIV DNA. We demonstrate that for specific cutting by IN, the cleavage site (the phosphodiester bond at the 3' side of the conserved CA-3' dinucleotide) must be located at a subterminal position in the viral DNA. We further investigated whether IN could carry out integration into single-stranded as well as double-stranded DNA.
MATERIALS AND METHODS
Construction of a plasmid expressing HIV-1 IN. The HIV-1 IN expression plasmid that we constructed is essentially the same as the plasmid described by Sherman and Fyfe (30) . The HIV-1 IN-coding sequence was derived from plasmid pHXB-2D (13) . The IN gene was subcloned into plasmid PiAN7 (29) to generate plasmid pRP177. The sequence 5'-ATAGAT-3' at positions 3822 to 3827 in the IN-coding sequence (24) was changed by oligonucleotide-directed mutagenesis to the sequence 5'-ATCGAT-3', which is a ClaI restriction site. In plasmid pRP177, the StuI site that is located at position 4985 (24) The sample was incubated at 80°C for 3 min and loaded onto a 12% denaturing polyacrylamide gel. After electrophoresis, an X-ray film (X-Omat AR; Eastman Kodak Co.) was exposed to the gel to localize the labeled oligonucleotide. The oligonucleotide was then cut from the gel and eluted for 16 h at 37°C in elution buffer (27) . After precipitation with ethanol, the oligonucleotide was resuspended in H20 to an end concentration of 0.2 pmol/I,l. Then 1 [lI (10 pmol GACTACCCGTCAGCGGGGGTrCTTT1rCATT Sherman and Fyfe (30) . Purified IN is shown on a silverstained SDS-polyacrylamide gel in Fig. 1 . Only a few other minor bands can be detected in the IN preparation. The identity of the 32-kDa IN band was determined by immunoblotting, using polyclonal antisera that were raised against an oligopeptide that is identical to the C-terminal 11 amino acids of HIV-1 IN (data not shown). We found that by using some modifications in the method of induction and lysis of the bacteria that express IN (see Materials and Methods), we obtained protein preparations that had a higher purity than -28 those previously described (30).
- 26 Sequence requirements for specific cleavage and integration. The sequence requirements for specific cleavage and integration of retroviral DNA by HIV-1 IN were determined in a physical assay. Initially, the activities of HIV-1 IN were tested on synthetic oligonucleotides that mimic the terminal 28 bp of HIV-1, HIV-2, and MoMLV DNA. The sequences of these oligonucleotide substrates are shown in Fig. 2A . Purified IN was incubated with the blunt-ended oligonucleotides under the appropriate reaction conditions (see Materials and Methods), and the products were electrophoresed in a denaturing polyacrylamide gel. Reaction products were visualized by autoradiography (Fig. 2B) . As was shown previously (4, 30) , HIV-1 IN is capable of specifically removing two nucleotides from the 3' ends of the HIV-1 U3 and U5 termini. After incubation with IN, a major product of 26 nucleotides could be seen, in addition to the band corresponding to the substrate. A minor but clear product of 24 nucleotides could also be detected, indicating that HIV-1 IN is also able to cleave, with a low efficiency, the phosphodiester bond between the G nucleotide at position 3 and -28 the C nucleotide at position 2 of the U5 sequence and - 26 between the two C nucleotides at positions 2 and 3 in the U3 sequence of HIV-1 ( Fig. 2A) . The relevance of cleavage at these positions is unknown. (18), and HIV-1 IN (4) that these bands represent products of integration of one oligonucleotide into another. Products that are shorter than 26 nucleotides can also be explained by integration, because the 3' ends of the cut made in the (5') labeled strand of the target DNA remain unjoined in the integration product. Specific cleavage and integration were not observed when the oligonucleotides were incubated with an extract from E. coli BL21(DE3) transformed with plasmid pET-3c (data not shown). This extract was subjected to the same purification procedure as was the HIV-1 IN preparation. HIV-1 IN is not able to cleave the MoMLV U5 oligonucleotide with high specificity (Fig. 2) . A nonspecific degradation ladder could be observed when the MoMLV substrate was incubated with IN.
We set out to determine the nucleotides present at the LTR ends of HIV-1 that are required for specific cleavage and integration by IN. For this purpose, we tested oligonucleotides that contain mutations relative to the oligonucleotide that represents the terminal 28 bp of the HIV-1 U5 sequence. The sequences of the different mutant substrates are shown in Fig. 2A . The results obtained from the cleavage and integration assay are depicted in Fig. 2B and summarized in Fig. 2A . Mutations that are located in the vicinity and at the 5' side of the IN cleavage site (the phosphodiester bond at the 3' side of the CA-3' dinucleotide at positions 1 and 2 in Fig. 2A in Fig. 2A ], no effect on cleavage and integration could be detected. This suggests that the terminal 15 Fig. 3A ; the results of the cleavage and integration assay are shown in Fig. 3B . It is clear that all substrates were cleaved at the phosphodiester bond that is located at the 3' side of the CA-3' dinucleotide. The blunt-ended substrate that does not contain any residues 3' of the CA-3' (substrate 1/2) cannot be specifically cleaved by IN. However, integrations of this substrate could be detected (Fig.  3B) . The wild-type oligonucleotide, having two nucleotides (GT-3') 3' of the CA-3' dinucleotide, was the best substrate for site-specific cleavage and integration by IN. Specific cleavage gradually decreased when more nucleotides were added to the 3' end. The oligonucleotide having six nucleotides 3' of the CA-3' sequence (substrate 13/14 in Fig. 3B 14) nucleotides, and the resulting substrates were incubated with IN (Fig. 3D) . The level of site-specific cleavage and integration (which could be observed after longer exposure of the gel; data not shown) was comparable to the wild-type level in all cases. Consequently, IN does not seem to be hindered by these 5' single-stranded extensions.
The cleavage and integration assays with the oligonucleotides shown in Fig. 3A were also performed with purified HIV-2 IN. The purification of HIV-2 IN will be described elsewhere (34a). HIV-2 IN was indeed able to specifically cleave the HIV-1 U5-derived substrates and showed a cleavage pattern similar to that of HIV-1 IN (Fig. 3E) . Also, in this case the wild-type substrate was cleaved more efficiently than the other oligonucleotides, and cleavage decreased gradually when more nucleotides were added to the 3' side of the conserved CA-3' dinucleotide. Enhanced cleavage was seen when the bases 3' of the CA-3' were present as single-stranded DNA, as was observed for the HIV-1 IN protein.
Specific cleavage and integration of 15-bp oligonucleotides. We showed that the terminal 15 bp of the LTRs of HIV-1 are sufficient for specific cleavage and integration by IN. These terminal 15 bp, however, were present on an oligonucleotide of 28 bp (Fig. 2) . Therefore, we wanted to determine whether an oligonucleotide of only the terminal 15 (Fig. 2) . We also tested duplex oligonucleotides that have 15 shown in Fig. 4B . The 15-bp substrate could indeed be cleaved by IN, but there were about equal amounts of cleavage product of 14 nucleotides (a nonspecific product) and of 13 nucleotides (the specific product). Integration products could also be observed when the 15-bp substrate was used. We conclude that the 15-bp oligonucleotide is a substrate for specific cleavage and integration but not as good a substrate as the 28-bp oligonucleotide. Specific cleavage was more efficient with the substrate in which the strand that is cleaved by IN had a length of 15 nucleotides and the complementary strand had a length of 28 nucleotides (substrate 18/6; Fig. 4B ). In addition, integration events were more frequent with this substrate than with the 15-bp substrate. It might be suggested that more nucleotides than the terminal 15 bp of the HIV-1 U5 sequence are required for recognition by IN. We have shown above, however, that all residues located more than 15 nucleotides away from the viral termini could be altered without a detectable effect on specific cutting. In combination with the observation that a single-stranded extension beyond position 15 from the terminus is sufficient to rescue high-efficiency cleavage, we suggest that IN is helped by the presence of any (nonspecific) extension to hold on to its viral recognition site.
Target specificity for integration. The largest products of integration of the 15-bp oligonucleotide were 24 nucleotides in length (Fig. 4B and data not shown) . This finding demonstrates that integration can take place at phosphodiester bonds that are located 4 nucleotides or more removed from the 5' end of the target DNA (13 nucleotides are obtained from the 3' recessed strand that integrates, and apparently the maximum length of the target DNA strand is 11 nucleotides). The largest product that resulted from integration of the wild-type substrate had a length of 50 nucleotides (as observed after longer electrophoresis of reaction products and overexposure of the gel; data not shown), which implies that the 26 nucleotides of the recessed donor oligonucleotide integrated 4 nucleotides or more removed from the 5' termini of a 28-bp target DNA. When substrate 18/6 was used, the largest integration products that could be detected were 38 nucleotides in length (Fig. 4B) , which means that in this case the integration site was 3 nucleotides or more removed from the termini of the target DNA. These experiments show that the integration site must be located at an internal position in the target DNA and at least three nucleotides away from the 5' end of the target DNA.
An interesting observation can be made when the maximal length of the integration product of substrate 5/17 is considered. The radiolabeled strand of the donor DNA that can integrate is 26 nucleotides long (after site-specific removal of two bases from the initial 28-nucleotide strand by IN); the complementary strand is 15 nucleotides long. If the target phosphodiester bond could be any bond in either oligonucleotide strand that is located 3 or more nucleotides away from a 5' end (see above), then the maximum length of the integration products is expected to be 51 nucleotides (26 plus 25). As shown in Fig. 4B , the ladder of integration products extends to a position corresponding to 40 nucleotides. This shows that the target site for efficient integration cannot be found in the 5' single-stranded region of the 28-nucleotide strand of substrate 5/17. Apparently, integration preferentially takes place into double-stranded DNA. Close inspection of Fig. 4B reveals faint bands that correspond to reaction products longer than 40 nucleotides. We can exclude that these bands represent the products of rare double integration events, since this explanation is not consistent with the observation that products larger than 40 nucleotides were not generated when substrate Fig. 2A Fig. 2A ) was changed to a T, low-efficiency cleavage was detected. However, integration events could not be detected when this substrate was used. This result could be explained by the fact that the A at position 1 of the HIV 3' ends is the nucleotide that is coupled to the target DNA. The importance of this A nucleotide for integration has also been observed for MoMLV (3) . In this case, the integration of plasmids, linearized by digestion with EcoRI, was studied in a genetic assay. It was shown that integration was favored when the termini of the plasmids were modified in such a way that an A nucleotide was present at the 3' ends.
A limited sequence requirement for integration has been described previously for the MoMLV IN protein, which was provided either as cytoplasmic extract from MoMLV-infected cells (37) (17, 22, 23, 33, 39) . We found that when only one nucleotide was present at the 3' side of the CA-3' sequence, the level of cleavage was less than with the wild-type substrate. The addition of more than two nucleotides to the 3' side of the CA-3' sequence resulted in a gradual decrease of site-specific cleavage. The finding that all oligonucleotides with more (or less) than two residues 3' of the conserved CA-3' were indeed cleaved at the phosphodiester bond 3' adjacent to the CA-3' implies that the cleavage site is determined by sequences internal to the LTR termini. This view is consistent with the observation that correct 3' recessed termini are formed in vivo and in vitro by MoMLV mutants that contain additional nucleotides 3' of the CA-3' dinucleotide (8, 26 
